Here's how you can reach us...
  • Tel:
  • Email:

Liposome Encapsulation Service for mRNAs

Inquiry

Messenger RNA (mRNA) is the template for protein biosynthesis. It is increasingly recognized as a crucial active molecule in combating various diseases, including viral infections and cancer. CD Formulation specializes in assisting clients in developing stable mRNA liposomal formulations by our liposome technology.

About mRNAs

mRNA is a single-stranded nucleic acid composed of four nucleotides--uracil, guanine, adenine, and cytosine. It is first synthesized from a DNA template. After that, the coding information is transmitted to ribosomes for protein translation. The length of mRNA varies significantly; after transcription, each molecule undergoes editing, capping, and polyadenylation before being released into the cytosol.

Fig.1 Schematic illustration of mRNA structure.Fig.1 Schematic illustration of mRNA. (Zhang W, et al, 2023)

Importance of Liposome mRNA Encapsulation

Fig.2 Key lipid nanocarriers of mRNA.Fig.2 Key lipid nanocarriers of mRNA: (A) liposome, lipoplex, and lipid nanoparticle; (B) nanostructured lipid carrier; (C) cationic nanoemulsion. (Aldosari, Basmah., et al., 2021)

Our Liposome-Based mRNA Encapsulation Service

Lipid selection and formulation design

We enhance the stability of liposomes through the systematic screening of lipid formulations. Lipids such as DOTAP can interact directly with cell surfaces via electrostatic interactions, facilitating their uptake by dendritic cells (DC) and subsequently promoting antigen presentation to bolster cellular immune responses. Furthermore, incorporating cholesterol into the DOTAP formulation can significantly improve liposome stability, while polyethylene glycol (PEG) serves to mitigate modulation effects and nonspecific uptake, thereby prolonging their circulation half-life in vivo. In certain instances, specifically synthesized cationic lipids that possess ionizable properties are required for various types of liposomes.

Liposome type selection

Our mRNA liposome delivery system can be classified into three categories: cationic, ionizable, and others. Among these, 1,2-di-O-octadecenyl-3-trimethylammonium propane (DOTMA) and dioleoyl-3-trimethylammonium propane (DOTAP) are utilized either independently or in conjunction with other materials in mRNA delivery systems. Additionally, our ionizable liposomes also assist our clients in studies related to cancer immunity and gene editing.

Characterization service

Our characterization of mRNA liposomes encompasses assessments of particle size, in vitro delivery, in vivo delivery, stability, and encapsulation efficiency.

Our Capabilities for Liposome mRNA Encapsulation

Techniques and Platforms Specifics
mRNA encapsulation technology
  • Lipid formulation development
  • Lipid synthesis and modification
  • Liposome type and methods screening
Characterization platform
  • In vitro evaluation techniques and in vivo evaluation techniques
  • Physical and chemistry evaluation
  • A wide range of characterization tools and instruments

Why Choose CD Formulation?

Published Data

Technology: Intranasal delivery of cationic liposome-protamine complex mRNA technique

Journal: Cellular Immunology

IF: 3.7

Published: 2020

Results: In this study, the authors investigated the methodology for administering mRNA through the nasal cavity, utilizing positively charged bovine prolactin to enhance mRNA concentration and form stable polycation-mRNA complexes, which were subsequently encapsulated in DOTAP/Chol/DSPE-PEG cationic liposomes. The LPC/bovine prolactin complex demonstrated superior vaccine particle uptake efficiency and a heightened capacity to stimulate dendritic cell maturation in vitro, thereby further eliciting a robust anti-tumor immune response. Intranasal delivery of mRNA encoding cytokeratin 19 to mice via cationic LPC resulted in a pronounced cellular immune response within an aggressive Lewis lung cancer model and impeded tumor growth. In this study, the authors substantiate that cationic LPC can serve as a safe and effective adjuvant. However, this mRNA formulation lays the groundwork for human anti-cancer vaccine administration.

Fig.3 The mechanism of Intranasal delivery of cationic liposome.Fig.3 The mechanism of Intranasal delivery of cationic liposome-protamine complex mRNA vaccine. (Mai Y, et al., 2020)

CD Formulation provides excellent mRNA liposome encapsulation services and technology for researchers. Our expertise ensures reliable and innovative solutions to support your scientific and development goals. Contact us to discuss how we can assist with your projects.

References

  1. Zhang W, Jiang Y, et al. Lipid carriers for mRNA delivery. Acta Pharmaceutica Sinica B. 2023 Oct 1; 13(10): 4105-26.
  2. Aldosari, Basmah., Alfagih, Iman., et al. Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. Pharmaceutics. 2021. 13. 206. 10.3390.
  3. Mai Y, Guo J, et al. Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity. Cellular Immunology. 2020 Aug 1; 354: 104143.
How It Works
STEP 2
We'll email you to provide your quote and confirm order details if applicable.
STEP 3
Execute the project with real-time communication, and deliver the final report promptly.
Related Services
Inquiry

CD Formulation is a global leader in liposome technology and formulation development, dedicated to providing pharmaceutical and biotechnology companies...

Learn More

  • Tel:
  • Email:

Stay up to date with our latest releases of new research and promotions.

Copyright © CD Formulation. All Rights Reserved.